Recruitment for laboratory roles, in particular, remains strong and are protected as ‘critical’ for many biotech firms. Decisions around talent acquisition for operational, manufacturing and corporate roles have been more challenging, especially in the current global climate. Some have frozen hiring, others are pressing ahead remotely.
The Biotech sector is benefitting from increased cross-over capabilities and platforms, that combine the latest data technologies, e.g. artificial intelligence or advanced analytics, with molecular and synthetic biology, genomic sciences, e.g. gene editing. These are used to support the development of highly personalised medicines and targeted therapeutics.
Businesses should consider that pools of qualified talent for scientific roles are limited and always in demand. Biotech firms need to distinguish themselves from competitors not only in salaries but with unique employee value propositions and by communicating their purpose to candidates who will engage actively with their vision.